Avoro Capital Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212M | Hold |
|
|||||
|
2025
Q1 | $267M | Hold |
|
|||||
|
2024
Q4 | $390M | Buy |
|
|||||
|
2024
Q3 | $320M | Hold |
|
|||||
|
2024
Q2 | $426M | Hold |
|
|||||
|
2024
Q1 | $653M | Hold |
|
|||||
|
2023
Q4 | $665M | Hold |
|
|||||
|
2023
Q3 | $423M | Hold |
|
|||||
|
2023
Q2 | $1.01B | Hold |
|
|||||
|
2023
Q1 | $733M | Buy |
|
|||||
|
2022
Q4 | $549M | Buy |
|
|||||
|
2022
Q3 | $692M | Buy |
|
|||||
|
2022
Q2 | $443M | Buy |
|
|||||
|
2022
Q1 | $480M | Buy |
|
|||||
|
2021
Q4 | $405M | Buy |
|
|||||
|
2021
Q3 | $165M | Buy |
|
|||||
|
2021
Q2 | $63.5M | Buy |
|
|||||
|
2021
Q1 | $42.9M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $7.45M | Hold |
|
|||||
|
2017
Q4 | $7.32M | Buy |
|